Reproductive Endocrinology for the MRCOG and Beyond. (Record no. 88234)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 08693nam a22004933i 4500 |
| 001 - CONTROL NUMBER | |
| control field | EBC3400000 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | MiAaPQ |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240729125442.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d | |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cnu|||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 240724s2007 xx o ||||0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781107710917 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9781904752196 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (MiAaPQ)EBC3400000 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (Au-PeEL)EBL3400000 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (CaPaEBR)ebr10511565 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)923353383 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | MiAaPQ |
| Language of cataloging | eng |
| Description conventions | rda |
| -- | pn |
| Transcribing agency | MiAaPQ |
| Modifying agency | MiAaPQ |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | QP252.R47 2007 |
| 082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 618.1 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Balen, Adam. |
| 245 10 - TITLE STATEMENT | |
| Title | Reproductive Endocrinology for the MRCOG and Beyond. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 2nd ed. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | London : |
| Name of producer, publisher, distributor, manufacturer | Cambridge University Press, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2007. |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | ©2007. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (225 pages) |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 490 1# - SERIES STATEMENT | |
| Series statement | Membership of the Royal College of Obstetricians and Gynaecologists and Beyond Series |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Cover -- Published titles in the MRCOG and Beyond series -- Contents -- Acknowledgments -- Preface to the first edition -- Preface to the second edition -- Abbreviations -- 1. Sexual differentiation: intersex disorders -- Development of the internal and external genitalia -- Origin of the ovaries and oocytes -- Origin of the uterus and fallopian tubes -- Development of external genitalia -- NEWBORN APPEARANCE -- Disorders of development of internal andexternal genitalia -- MULLERIAN DUCT ABNORMALITIES -- CONGENITAL ABSENCE OF THE VAGINA -- FUSION ABNORMALITIES OF THE VAGINA -- MULLERIAN/UTERINE ANOMALIES -- Androgen insensitivity syndrome -- 5-ALPHA REDUCTASE DEFICIENCY -- Congenital adrenal hyperplasia -- Cloacal anomalies -- Management of intersex conditions -- Reference -- 2. Adrenal disorders -- The adrenal medulla -- EFFECTS OF ADRENALINE AND NORADRENALINE -- PHAEOCHROMOCYTOMA -- The adrenal cortex -- HYPERFUNCTION OF THE ADRENAL CORTEX -- 3. Normal puberty and adolescence -- Pubertal development -- ONSET OF PUBERTAL DEVELOPMENT -- References -- 4. Abnormal puberty -- Precocious puberty -- TRUE PRECOCIOUS PUBERTY -- PREMATURE THELARCHE -- THELARCHE VARIANT -- PREMATURE ADRENARCHE -- CONGENITAL ADRENAL HYPERPLASIA -- PERIPHERAL TUMOURS -- MANAGEMENT OF PRECOCIOUS PUBERTY -- CONSTITUTIONAL DELAY OF GROWTH AND PUBERTY -- TURNER SYNDROME -- POLYGLANDULAR AUTOIMMUNE SYNDROMES -- CONGENITAL HYPOGONADOTROPHIC HYPOGONADISM -- MANAGEMENT OF DELAYED PUBERTY -- Delayed puberty -- CONSTITUTIONAL DELAY OF GROWTH AND PUBERTY -- TURNER SYNDROME -- POLYGLANDULAR AUTOIMMUNE SYNDROMES -- CONGENITAL HYPOGONADOTROPHIC HYPOGONADISM -- MANAGEMENT OF DELAYED PUBERTY -- Reference -- 5. The menstrual cycle -- Ovulation during the perimenopausal transition -- References -- 6. Disorders of menstruation -- Normal menstruation -- VARIATION IN MENSTRUAL BLOOD LOSS. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | VARIATION IN CYCLE LENGTH AND DURATION OF MENSTRUATION -- The abnormal menstrual cycle -- MENORRHAGIA -- ASSESSMENT OF MENSTRUAL BLOOD LOSS -- CAUSES OF MENORRHAGIA -- DIAGNOSIS OF MENORRHAGIA -- Methods of endometrial assessment -- ENDOMETRIAL BIOPSY -- HYSTEROSCOPY -- TRANSVAGINAL ULTRASOUND -- Initial management of menorrhagia in primary care -- Medical treatment of menorrhagia -- NON-HORMONAL TREATMENTS -- HORMONAL TREATMENTS -- TREATMENT FAILURES -- Surgical treatment of menorrhagia -- HYSTERECTOMY -- OVARIES AND HYSTERECTOMY -- ENDOMETRIAL ABLATIVE TECHNIQUES -- COMPARISON OF ENDOMETRIAL ABLATIVE TECHNIQUES WITH HYSTERECTOMY -- Counselling in menorrhagia -- The ideal management of menorrhagia -- Fibroids -- MANAGEMENT -- Dysmenorrhoea -- PRIMARY DYSMENORRHOEA -- SECONDARY DYSMENORRHOEA -- TREATMENT -- ASSESSMENT -- References -- 7. Amenorrhoea -- Primary amenorrhoea -- Secondary amenorrhoea -- Examination and investigation of amenorrhoea -- Causes of amenorrhoea -- GENITAL TRACT ABNORMALITIES -- SYSTEMIC DISORDERS CAUSING SECONDARY AMENORRHOEA -- WEIGHT-RELATED AMENORRHOEA -- LEPTIN -- PSYCHOLOGICAL STRESS -- EXERCISE-RELATED AMENORRHOEA -- HYPOTHALAMIC CAUSES OF SECONDARY AMENORRHOEA -- PITUITARY CAUSES OF SECONDARY AMENORRHOEA -- IATROGENIC CAUSES OF AMENORRHOEA -- 8. Polycystic ovary syndrome -- Pathogenesis -- GENETICS OF POLYCYSTIC OVARY SYNDROME -- HETEROGENEITY OF POLYCYSTIC OVARY SYNDROME -- Management of polycystic ovary syndrome -- OBESITY -- MENSTRUAL IRREGULARITY -- INFERTILITY -- HYPERANDROGENISM AND HIRSUTISM -- References -- 9. Health consequences of polycystic ovary syndrome -- Insulin resistance -- Insulin resistance in polycystic ovary syndrome -- Other risk factors for ischaemic heart disease in women with polycystic ovary syndrome -- CENTRAL OBESITY -- IMPAIRED GLUCOSE TOLERANCE AND DIABETES -- HYPERTENSION -- DYSLIPIDAEMIA. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | HYPERHOMOCYSTEINAEMIA -- Polycystic ovary syndrome in younger women -- Long-term follow-up in polycystic ovary syndrome -- Therapeutic options -- Polycystic ovary syndrome and cancer -- ENDOMETRIAL CANCER -- BREAST CANCER -- OVARIAN CANCER -- References -- 10. Anovulatory infertility andovulation induction -- Pituitary and hypothalamic causes of anovulation -- HYPOGONADOTROPHIC HYPOGONADISM -- WEIGHT-RELATED AMENORRHOEA -- Polycystic ovary syndrome (see also Chapter 8) -- LIFESTYLE AND WEIGHT LOSS IN POLYCYSTIC OVARY SYNDROME -- CLOMIFENE CITRATE THERAPY -- AROMATASE INHIBITORS -- GONADOTROPHIN THERAPY -- SURGICAL OVULATION INDUCTION -- THE ROLE OF METFORMIN AND OTHER INSULIN SENSITISERS -- IVF IN WOMEN WITH POLYCYSTIC OVARIES -- IN VITRO MATURATION OF OOCYTES -- Risks of ovulation induction -- Ovarian hyperstimulation syndrome -- MANAGEMENT OF OVARIAN HYPERSTIMULATION SYNDROME -- Summary -- References -- 11. Lactation and lactational amenorrhoea -- Initiation of lactation -- Maintenance of lactation and milk letdown -- Endocrine effects of lactation -- AMENORRHOEA -- HYPOESTROGENAEMIA -- SOCIAL EFFECTS -- Metabolic effects of lactation -- DIET -- WEIGHT CHANGE -- CONTROL OF LACTATION -- Lactation and contraception -- NATURAL CONTRACEPTION -- ARTIFICIAL CONTRACEPTION -- References -- 12. Hyperprolactinaemia -- MEDICAL MANAGEMENT -- SURGICAL MANAGEMENT -- EFFECT ON PREGNANCY -- Reference -- 13. Thyroid disease -- Scientific background -- Thyroid function -- CLINICAL EXAMINATION OF THE THYROID GLAND -- Classification and diagnosis (Table 13.2) -- SIMPLE NON-TOXIC GOITRE -- HYPOTHYROIDISM -- HYPERTHYROIDISM -- 14. Diabetes -- Definition -- Treatment and control -- Relevance to fertility -- Relevance to pregnancy -- Management of diabetes in pregnancy -- Managing the complications of diabetes inpregnancy. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Managing the complications of pregnancy in women with diabetes -- Type 2 diabetes, hyperinsulinaemia and insulin resistance -- References -- 15. Lipid metabolism and lipoprotein transport -- Transport of dietary fat -- HEPATIC LIPID METABOLISM -- ENDOGENOUS LIPID TRANSPORT -- HIGH-DENSITY LIPOPROTEINS AND REVERSE CHOLESTEROL TRANSPORT -- The effect of menopause on plasma lipoproteins -- References -- 16. Premature ovarian failure -- The control of ovarian ageing -- Definition and diagnosis -- Causation -- GENETIC CAUSES -- FAMILIAL FACTORS -- AUTOIMMUNE CAUSES -- Management -- OOCYTE DONATION -- CRYOPRESERVATION OF OVARIAN TISSUE -- References -- 17. Calcium metabolism and its disorders -- Calcium and bone homeostasis -- Parathyroid hormone and calcium -- Renal disease and calcium -- Osteoporosis and calcium -- References -- Appendix: Endocrine normal ranges -- Further reading -- Index. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Understanding endocrinology is central to understanding the key processes that affect normal reproductive function and when dealing with reproductive disorders. Primarily aimed at candidates preparing for the Part 2 MRCOG examination, this book provides a comprehensive background for all working in reproductive medicine. |
| 588 ## - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Description based on publisher supplied metadata and other sources. |
| 590 ## - LOCAL NOTE (RLIN) | |
| Local note | Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Human reproduction -- Endocrine aspects. |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Print version: |
| Main entry heading | Balen, Adam |
| Title | Reproductive Endocrinology for the MRCOG and Beyond |
| Place, publisher, and date of publication | London : Cambridge University Press,c2007 |
| International Standard Book Number | 9781904752196 |
| 797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN) | |
| Corporate name or jurisdiction name as entry element | ProQuest (Firm) |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | Membership of the Royal College of Obstetricians and Gynaecologists and Beyond Series |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3400000">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3400000</a> |
| Public note | Click to View |
No items available.